This study enrolled a total of 90 participants, divided into three groups: 30 patients with RA receiving csDMARDs and glucocorticoids, 30 patients with RA treated with TNF-α inhibitors, and 30 healthy individuals. Here, TNF is linked to rheumatoid arthritis.